Effect of Gamma-cyclodextrin on the Bioavailability of Ginsenosides

Clinical trial NCT04932265 · SUSPENDED

Trial details

NCT number: NCT04932265
Sponsor: EuroPharma, Inc.
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Absorption

Start date: 2021-09-01
Primary completion: 2024-12-20
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.